Avalo Therapeutics
AVTX
AVTX
53 hedge funds and large institutions have $131M invested in Avalo Therapeutics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
Holders
53
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.16M | |
| 2 | +$602K | |
| 3 | +$320K | |
| 4 |
AC
Armistice Capital
New York
|
+$312K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$243K |
Top Sellers
| 1 | -$1.98M | |
| 2 | -$303K | |
| 3 | -$274K | |
| 4 |
Renaissance Technologies
New York
|
-$246K |
| 5 |
Two Sigma Advisers
New York
|
-$235K |